ROBERT RUIZ: Open Payments
NPI 1720147077 · EL CENTRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 17 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $442 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $101 |
| PFIZER INC. | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| ABBVIE INC. | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Daiichi Sankyo Inc. | 1 | $25 |
Products named: Wegovy, JARDIANCE, AREXVY, Ozempic, VOQUEZNA, PREVNAR 20, LINZESS, INJECTAFER.
Industry payments across CA — which companies pay providers there.
